This Advisory Notice supersedes CME Group Market Regulation Advisory Notice RA1503-5 issued on March 24, 2015. It is being issued based on an upcoming amendment to Rule 512 (“Reporting Infractions”) which ensures that the Chief Regulatory Officer or his designee will have authority to impose summary fines on any party who has consented to the jurisdiction of the Exchange.
Click HERE to view the full advisory.
CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.